down arrow

Evoq Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0JVD01011
  • NSEID:
  • BSEID: 543500
INR
2.86
0.05 (1.78%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 4000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.0 k (-88.37%) Volume

Shareholding (Sep 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

11.21%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 7 Cr (Micro Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.16

stock-summary
Return on Equity

1.78%

stock-summary
Price to Book

0.28

Revenue and Profits (1 Year):
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-63.84%
0%
-63.84%
1 Year
-74.26%
0%
-74.26%
2 Years
-77.36%
0%
-77.36%
3 Years
-83.7%
0%
-83.7%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Evoq Remedies for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-18.30%
EBIT Growth (5y)
-189.79%
EBIT to Interest (avg)
-0.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.07
Sales to Capital Employed (avg)
0
Tax Ratio
29.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
25.57%
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
33
Price to Book Value
0.28
EV to EBIT
-6.73
EV to EBITDA
-6.78
EV to Capital Employed
0.38
EV to Sales
2.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.62%
ROE (Latest)
1.78%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Patel Payal Bhumishth (6.02%)

Highest Public shareholder

Dhruv Ganji (11.35%)

Individual Investors Holdings

85.75%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Evoq Remedies"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2025 is 0.00% vs -100.00% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2025 is 205.56% vs -515.38% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.76",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.61",
          "val2": "-1.64",
          "chgp": "62.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.71",
          "val2": "-1.62",
          "chgp": "205.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-5.19%",
          "val2": "0.00%",
          "chgp": "-5.19%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Evoq Remedies"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 190.37% vs -80.14% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -80.00% vs -72.22% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.76",
          "val2": "4.05",
          "chgp": "190.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.23",
          "val2": "-1.64",
          "chgp": "-35.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.09",
          "val2": "0.45",
          "chgp": "-80.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-18.96%",
          "val2": "-40.49%",
          "chgp": "21.53%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Half Yearly Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Sep'24
Change(%)
Net Sales
11.76
0.00
Operating Profit (PBDIT) excl Other Income
-0.61
-1.64
62.80%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
1.71
-1.62
205.56%
Operating Profit Margin (Excl OI)
-5.19%
0.00%
-5.19%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Mar 2025 is 0.00% vs -100.00% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Mar 2025 is 205.56% vs -515.38% in Sep 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
11.76
4.05
190.37%
Operating Profit (PBDIT) excl Other Income
-2.23
-1.64
-35.98%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.09
0.45
-80.00%
Operating Profit Margin (Excl OI)
-18.96%
-40.49%
21.53%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 190.37% vs -80.14% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -80.00% vs -72.22% in Mar 2024

stock-summaryCompany CV
About Evoq Remedies Ltd stock-summary
stock-summary
Evoq Remedies Ltd
Micro Cap
Pharmaceuticals & Drugs
Evoq Remedies Limited was originally incorporated as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 vide Certificate of Incorporation issued by Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, name of the Company was changed to "Evoq Remedies Private Limited" on July 15th, 2019 with Certificate of Incorporation pursuant to change of name issued by Registrar of Companies, Ahmedabad.
Company Coordinates stock-summary
Icon
No Company Details Available